Spotlight
Video

Most Anticipated Trial Results Regarding Biomarkers in RCC

obr has 860 videos Subscribe Here

Loading........
Description: Tian Zhang , MD, Assistant Professor of Medicine, Duke Cancer Institute, explains the anticipated trial results involving I-O, TKIs and biomarkers in renal cell carcinoma (RCC).
Shared By : obr
Posted on : 07/02/19
Added : 14 days ago
Category : Kidney Cancer